1.Prognostic factors for patients with bone metastasis from primary liver carcinoma:a report of 55 cases
Practical Oncology Journal 2015;(4):327-332
Objective To improve the clinical diagnosis and prognosis of the treatment of primary liver carcinoma with bone metastasis.Methods A retrospective study on diagnosis and treatment of bone metastasis from 55 cases of primary liver carcinoma was developed.Survival rates were calculated by Kaplan-meier meth-od,univariates analysed by Log-rank and multivariates analysed by Cox regression.Results The 1-,2-and 3-year cumulative survival rates of the cases from primary liver carcinoma were 54.5%,25.5%and 16.4%re-spectively.The mediate survival time was 13 months.And the cases with bone metastasis were 23.6%,10.9%and 1.8%respectively.The mediate survival time was 5.5 months.Factors such as metastasis to other organs,liv-er function,and the combined modality therapy were independent prognostic factors.While number of bone metas-tasis,AFP level and number of liver cancer had no significant relations with the survival rate.Conclusion The prognosis of bone metastasis from primary liver carcinoma is poor.It is important to take emphasis on combined mo-dality therapy,which may be benefit on reducing the symptom,improving the quality and prolong the life span.
2.Report of two cases of hepatitis B virus reactivation in primary liver carcinoma patients treated with the FOLFOX chemotherapy regimen.
Feng WANG ; Shukui QIN ; Haiqing HUA ; Xiufeng LIU ; Wenshu QU ; Ping LI
Chinese Journal of Hepatology 2014;22(3):236-238
Adult
;
Antineoplastic Combined Chemotherapy Protocols
;
adverse effects
;
Fluorouracil
;
adverse effects
;
Hepatitis B virus
;
drug effects
;
physiology
;
Humans
;
Leucovorin
;
adverse effects
;
Liver Neoplasms
;
drug therapy
;
pathology
;
Male
;
Middle Aged
;
Neoplasm Staging
;
Organoplatinum Compounds
;
adverse effects
;
Virus Activation
;
drug effects